2.63
-0.07 (-2.59%)
| 前收盘价格 | 2.70 |
| 收盘价格 | 2.65 |
| 成交量 | 2,398 |
| 平均成交量 (3个月) | 2,583 |
| 市值 | 10,970,151 |
| 价格/销量 (P/S) | 0.200 |
| 股市价格/股市净资产 (P/B) | 5.77 |
| 52周波幅 | |
| 利润日期 | 5 May 2025 - 9 May 2025 |
| 营业毛利率 | -27.22% |
| 营业利益率 (TTM) | -29.58% |
| 稀释每股收益 (EPS TTM) | -2.27 |
| 季度收入增长率 (YOY) | 0.90% |
| 总债务/股东权益 (D/E MRQ) | 614.35% |
| 流动比率 (MRQ) | 1.05 |
| 杠杆自由现金流 (LFCF TTM) | 1.80 M |
| 资产报酬率 (ROA TTM) | -7.60% |
| 股东权益报酬率 (ROE TTM) | -151.23% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | Strata Skin Sciences, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -4.0 |
| 平均 | -1.17 |
|
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 4.02% |
| 机构持股比例 | 64.08% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Financial Perspectives, Inc | 31 Mar 2025 | 101 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合